For research and educational purposes only. Not medical advice.
P021 Reference
Educational, not medical advice reference for P021: Cognitive, Longevity; regulatory status, evidence posture, source review, and schedule notes. Also known…
Reference summary
Mouse studies in 3xTg Alzheimer models report changes in tau, amyloid, neurogenesis, synaptic plasticity, and cognition. Human clinical efficacy data are absent.
- Categories
- Cognitive, Longevity
- Aliases
- Peptide 021, CNTF-derived peptide mimetic, Ac-DGGLAG-NH2
- Evidence posture
- preclinical — Animal-model neurodegeneration signal only. Community nootropic and anti-Alzheimer claims are unproven and should not be treated as clinical evidence.
- Regulatory status
- No FDA-approved P021 drug label. P021 is an investigational CNTF-derived peptide mimetic studied primarily in Alzheimer-model animals, not an approved nootropic or dementia treatment.
- Content review status
- research reference